MedTrace Logo

Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma

NCT05190263 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1053

Last updated 2022-02-15

No results posted yet for this study

Summary

The aim of the study is to analyze the implementation of the 2018 updated ESMO Guideline in patients with tumor diseases as well as the corre-sponding recommendations of the Onkopedia Guideline and the S3 Guide-line Supportive Therapy in routine clinical practice in Germany.

To this end, a nationwide, representative, retrospective patient documen-tation will be conducted to observe the current practice of anemia man-agement in hospitals and among office-based physicians.

Conditions

  • Anemia, Iron Deficiency
  • Solid Tumor
  • Malignant Lymphoma

Interventions

OTHER

non-interventional retrospective epidemiological observational study

non-interventional retrospective epidemiological observational study

Sponsors & Collaborators

  • Prof. Hartmut Link

    collaborator UNKNOWN

  • MMF GmbH

    collaborator INDUSTRY

  • AIO AG Supportivtherapie

    collaborator OTHER

  • AG Supportive Maßnahmen in der Onkologie

    collaborator OTHER

  • AIO-Studien-gGmbH

    lead OTHER

Principal Investigators

  • Hartmut Link, Prof. Dr. · AIO AG Supportive Therapie

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2022-02-06
Completion
2022-02-06

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05190263 on ClinicalTrials.gov